Coppell Advisory Solutions’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,188
Closed -$444K 235
2025
Q4
$444K Buy
+4,188
New +$393K 0.04% 269
2025
Q1
Sell
-599
Closed -$59.5K 1273
2024
Q4
$59.5K Sell
599
-807
-57% -$83.2K 0.01% 534
2024
Q3
$160K Sell
1,406
-996
-41% -$118K 0.02% 322
2024
Q2
$297K Buy
+2,402
New +$309K 0.05% 204
2023
Q4
$311K Sell
2,853
-1,668
-37% -$173K 0.06% 201
2023
Q3
$502K Buy
4,521
+3,757
+492% +$405K 0.17% 110
2023
Q2
$86.7K Buy
+764
New +$86.7K 0.02% 285
2023
Q1
Sell
-2,759
Closed -$306K 738
2022
Q4
$306K Buy
+2,759
New +$282K 0.1% 137
2020
Q4
$1.26M Buy
+16,139
New +$1.23M 0.64% 39

Other funds holding MRK

Coppell Advisory Solutions's MRK Position: Q1 2026 in Review

Coppell Advisory Solutions sold out of Merck (MRK) in Q1 2026, closing a stake of 4,188 shares — an estimated $444K sold.

Coppell Advisory Solutions first reported a position in MRK in Q4 2020 and held it in 9 quarters. The position peaked at $1.26M in Q4 2020. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Coppell Advisory Solutions reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Coppell Advisory Solutions sold 4,188 Merck shares in Q1 2026, an estimated $444K.
  • Coppell Advisory Solutions first reported a position in Merck in Q4 2020 and held it in 9 quarters.
  • Coppell Advisory Solutions's Merck position peaked at $1.26M in Q4 2020.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Coppell Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.